Arcoma AB Cash Flow Conversion Efficiency

Latest as of March 2026: 0.001x

Arcoma AB cash flow conversion efficiency. Based on the latest financial reports, Arcoma AB (ARCOMA) has a cash flow conversion efficiency ratio of 0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr68.00K ≈ $7.32K USD) by net assets (Skr75.54 Million ≈ $8.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Arcoma AB (2012–2025)

Cash flow conversion efficiency of Arcoma AB from 2012 to 2025. This chart illustrates how Arcoma AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Arcoma AB stock quote for real-time trading data and today's change.

Arcoma AB Cash Flow Conversion Ratio Explained

Arcoma AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Arcoma AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Arcoma AB ranked by their cash flow conversion efficiency. Also see ARCOMA company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Venteny Fortuna International JK:VTNY	-0.027x
Biofrontera Inc NASDAQ:BFRI	-0.278x
MESB Bhd KLSE:7234	0.049x
Mr. Onion TWO:2740	0.069x
Elementis PLC LSE:ELM	0.069x
OXE Marine AB ST:OXE	-0.326x
Khind Holdings Bhd KLSE:7062	0.064x
California Nanotechnologies Corp V:CNO	-0.223x

Annual Cash Flow Conversion Efficiency for Arcoma AB (2012–2025)

The table below shows the annual cash flow conversion efficiency of Arcoma AB from 2012 to 2025. Review Arcoma AB (ARCOMA) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr74.73 Million ≈ $8.04 Million	Skr18.72 Million ≈ $2.01 Million	0.251x	-21.13%
2024-12-31	Skr59.33 Million ≈ $6.39 Million	Skr18.84 Million ≈ $2.03 Million	0.318x	-19.34%
2023-12-31	Skr48.66 Million ≈ $5.24 Million	Skr19.16 Million ≈ $2.06 Million	0.394x	+10191.91%
2022-12-31	Skr45.88 Million ≈ $4.94 Million	Skr-179.00K ≈ $-19.26K	-0.004x	+91.11%
2021-12-31	Skr44.04 Million ≈ $4.74 Million	Skr-1.93 Million ≈ $-207.91K	-0.044x	-131.74%
2020-12-31	Skr49.53 Million ≈ $5.33 Million	Skr6.85 Million ≈ $736.74K	0.138x	-43.73%
2019-12-31	Skr45.19 Million ≈ $4.86 Million	Skr11.10 Million ≈ $1.19 Million	0.246x	+21208.34%
2018-12-31	Skr39.03 Million ≈ $4.20 Million	Skr45.00K ≈ $4.84K	0.001x	+100.53%
2017-12-31	Skr40.83 Million ≈ $4.39 Million	Skr-8.91 Million ≈ $-958.86K	-0.218x	-74.65%
2016-12-31	Skr37.35 Million ≈ $4.02 Million	Skr-4.67 Million ≈ $-502.14K	-0.125x	-26.04%
2015-12-31	Skr49.92 Million ≈ $5.37 Million	Skr-4.95 Million ≈ $-532.48K	-0.099x	-399.55%
2014-12-31	Skr41.73 Million ≈ $4.49 Million	Skr-828.00K ≈ $-89.11K	-0.020x	+97.90%
2013-12-31	Skr12.52 Million ≈ $1.35 Million	Skr-11.82 Million ≈ $-1.27 Million	-0.944x	-122.06%
2012-12-31	Skr24.14 Million ≈ $2.60 Million	Skr-10.27 Million ≈ $-1.10 Million	-0.425x	--

About Arcoma AB

ST:ARCOMA Sweden Medical Devices

Market Cap

$13.21 Million

Skr122.77 Million SEK

Market Cap Rank

#26198 Global

#541 in Sweden

Share Price

Skr8.58

Change (1 day)

-2.28%

52-Week Range

Skr6.92 - Skr9.80

All Time High

Skr25.60